Global University Venturing

Zurich immuno-oncology spinout Anaveon raised $35.1m from Novartis Venture Fund and Syncona in addition to seed-stage notes converted by the UZH Life Sciences Fund.

Russian Academy of Sciences spinout PM&HM has signed up a second government-owned vehicle to help commercialise its digitally-enabled inhaler for tuberculosis, cancer and HIV.

The MIT-founded manufacturing app development spinout has now received more than $31m from investors including Vertex Ventures US, Pitango, NEA and C4 Ventures.

NIH will provide $3.5m to establish a human health-focused accelerator in five US states, with space for five biotech projects in its initial cohort.

VoiceAI Technologies collected funding from investors including Hong Kong X Technology Fund after launching a research collaboration with Hong Kong University of Science Technology.

MIT spinout Ginkgo Bioworks has set up Motif Ingredients with $90m in series A funding provided by investors including Louis Dreyfus Company and Fonterra.

The private equity firm’s latest fund has closed with $2.1bn from backers including endowments for specialty materials, chemicals and pharmaceuticals investments.

Based on OSU research, Pellucere Technologies is to begin selling its soil resistant solar panel coating having previously disclosed a $3m equity investment in November last year.

NovaUCD has helped spawn 45 spinouts since 2003 and offered innovation support to companies which generated more than $128m of combined turnover during 2018.

Spark Therapeutics publicly listed in 2015 and is set to net Children's Hospital of Philadelphia up to $458m following its acquisition by Roche.

Fraunhofer Venture has unveiled an accelerator for businesses based on its research in areas including artificial intelligence, digital medicine and industry 4.0.